PTMA and non-small cell lung carcinoma: In the case of prothymosin alpha (PTMA) protein, in which overexpression indicates a poor prognosis for most cancers, its inhibition described in non-small cell lung cancer allows cells to be sensitised to radiation therapy (Jiang et al., 2021).